Unique sequence features of the human adenovirus 31 complete genomic sequence are conserved in clinical isolates

BMC Genomics

Volumn 10, Issue , 2009, Pages

  Hofmayer, Soeren ^a   Madisch, Ijad ^a,b   Darr, Sebastian ^a   Rehren, Fabienne ^a   Heim, Albert ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOSINE; E1A PROTEIN; E1B PROTEIN; GUANINE; VIRUS PROTEIN;

ARTICLE; BASE PAIRING; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; GENE SEQUENCE; GENOME SIZE; HUMAN; HUMAN ADENOVIRUS; HUMAN CELL; IMMUNOSURVEILLANCE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN MOTIF; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY; STRAIN DIFFERENCE; VIRAL GENETICS; VIRUS CELL INTERACTION; VIRUS GENOME; VIRUS IMMUNITY; VIRUS ISOLATION; VIRUS STRAIN; VIRUS TYPING; VIRUS VIRULENCE; ADENOVIRUS; AMINO ACID SEQUENCE; CHEMISTRY; GENETICS; ISOLATION AND PURIFICATION; LONG TERMINAL REPEAT; MOLECULAR GENETICS; OPEN READING FRAME; PATHOGENICITY; PHYLOGENY; VIRULENCE; VIRUS GENE;

ADENOVIRIDAE; HUMAN ADENOVIRUS;

ADENOVIRIDAE; AMINO ACID MOTIFS; AMINO ACID SEQUENCE; BASE SEQUENCE; CONSERVED SEQUENCE; GENES, VIRAL; GENOME, VIRAL; HUMANS; MOLECULAR SEQUENCE DATA; OPEN READING FRAMES; PHYLOGENY; SEQUENCE ALIGNMENT; TERMINAL REPEAT SEQUENCES; VIRAL PROTEINS; VIRULENCE;

EID: 72549090873     PISSN: None     EISSN: 14712164     Source Type: Journal    
DOI: 10.1186/1471-2164-10-557     Document Type: Article

References (66)

1. Swenson PD, Wadell G, Allard A, Hierholzer JC. Adenoviruses. Manual of Clinical Microbiology 2003, 2:1404-1417. Washington, D.C.: ASM Press, Murray PR, Baron EJ, Pfaller MA, Jorgensen JH, Yolken RA.
2. Benkö M, Harrach B, Russell WC. Adenoviridea. Virus taxonomy Seventh report of the international Commitee on Taxonomy of Viruses 2000, New York, N.Y.: Academic Press.
3. Shenk T. Adenoviridae: The viruses and their replication. 2001, New York: Lippincott-Raven publishers.
4. Jones MS, Harrach B, Ganac RD, Gozum MM, Dela Cruz WP, Riedel B, Pan C, Delwart EL, Schnurr DP. New Adenovirus Species Found in Patient Presenting with Gastroenteritis. J Virol 2007, 81(11):5978-5984. 10.1128/JVI.02650-06, 1900323, 17360747.
5. Crawford-Miksza LK, Nang RN, Schnurr DP. Strain variation in adenovirus serotypes 4 and 7a causing acute respiratory disease. J Clin Microbiol 1999, 37(4):1107-1112. 88656, 10074533.
6. Erdman DD, Xu W, Gerber SI, Gray GC, Schnurr D, Kajon AE, Anderson LJ. Molecular epidemiology of adenovirus type 7 in the United States, 1966-2000. Emerg Infect Dis 2002, 8(3):269-277. 10.3201/eid0803.010190, 2732469, 11927024.
7. Bhat AM, Meny RG, Aranas EA, Yehia F. Fatal adenoviral (type 7) respiratory disease in neonates. Clin Pediatr (Phila) 1984, 23(7):409-411. 10.1177/000992288402300710, 6327136.
8. Chuang YY, Chiu CH, Wong KS, Huang JG, Huang YC, Chang LY, Lin TY. Severe adenovirus infection in children. J Microbiol Immunol Infect 2003, 36(1):37-40.
9. Dakhama A, Hegele RG, Laflamme G, Israel-Assayag E, Cormier Y. Common respiratory viruses in lower airways of patients with acute hypersensitivity pneumonitis. Am J Respir Crit Care Med 1999, 159(4 Pt 1):1316-1322.
10. Kampmann B, Cubitt D, Walls T, Naik P, Depala M, Samarasinghe S, Robson D, Hassan A, Rao K, Gaspar H. Improved outcome for children with disseminated adenoviral infection following allogeneic stem cell transplantation. Br J Haematol 2005, 130(4):595-603. 10.1111/j.1365-2141.2005.05649.x, 16098075.
11. Chakrabarti S, Mautner V, Osman H, Collingham KE, Fegan CD, Klapper PE, Moss PA, Milligan DW. Adenovirus infections following allogeneic stem cell transplantation: incidence and outcome in relation to graft manipulation, immunosuppression, and immune recovery. Blood 2002, 100(5):1619-1627. 10.1182/blood-2002-02-0377, 12176880.
12. Hale GA, Heslop HE, Krance RA, Brenner MA, Jayawardene D, Srivastava DK, Patrick CC. Adenovirus infection after pediatric bone marrow transplantation. Bone Marrow Transplant 1999, 23(3):277-282. 10.1038/sj.bmt.1701563, 10084260.
13. Walls T, Shankar AG, Shingadia D. Adenovirus: an increasingly important pathogen in paediatric bone marrow transplant patients. Lancet Infect Dis 2003, 3(2):79-86. 10.1016/S1473-3099(03)00515-2, 12560192.
14. Venard V, Carret A, Corsaro D, Bordigoni P, Le Faou A. Genotyping of adenoviruses isolated in an outbreak in a bone marrow transplant unit shows that diverse strains are involved. J Hosp Infect 2000, 44(1):71-74. 10.1053/jhin.1999.0656, 10633057.
15. Seidemann K, Heim A, Pfister ED, Köditz H, Beilken A, Sander A, Melter M, Sykora KW, Sasse M, Wessel A. Monitoring of adenovirus infection in pediatric transplant recipients by quantitative PCR: report of six cases and review of the literature. Am J Transplant 2004, 4(12):2102-2108. 10.1111/j.1600-6143.2004.00631.x, 15575915.
16. Madisch I, Wolfel R, Harste G, Pommer H, Heim A. Molecular identification of adenovirus sequences: a rapid scheme for early typing of human adenoviruses in diagnostic samples of immunocompetent and immunodeficient patients. J Med Virol 2006, 78(9):1210-1217. 10.1002/jmv.20683, 16847954.
17. Mattner F, Sykora KW, Meissner B, Heim A. An Adenovirus Type F41 Outbreak in a Pediatric Bone Marrow Transplant Unit: Analysis of Clinical Impact and Preventive Strategies. Pediatr Infect Dis J 2008, 27(5):419-424. 10.1097/INF.0b013e3181658c46, 18382384.
18. Slatter MA, Read S, Taylor CE, Crooks BN, Abinun M, Flood TJ, Cant AJ, Wright C, Gennery AR. Adenovirus type F subtype 41 causing disseminated disease following bone marrow transplantation for immunodeficiency. J Clin Microbiol 2005, 43(3):1462-1464. 10.1128/JCM.43.3.1462-1464.2005, 1081290, 15750134.
19. Waddington SN, McVey JH, Bhella D, Parker AL, Barker K, Atoda H, Pink R, Buckley SM, Greig JA, Denby L. Adenovirus serotype 5 hexon mediates liver gene transfer. Cell 2008, 132(3):397-409. 10.1016/j.cell.2008.01.016, 18267072.
20. Jonsson MI, Lenman AE, Frangsmyr L, Nyberg C, Abdullahi M, Arnberg N. Coagulation factors IX and X enhance binding and infection of adenovirus types 5 and 31 in human epithelial cells. J Virol 2009, 83(8):3816-3825. 10.1128/JVI.02562-08, 2663266, 19158249.
21. Garnett CT, Talekar G, Mahr JA, Huang W, Zhang Y, Ornelles DA, Gooding LR. Latent species C adenoviruses in human tonsil tissues. J Virol 2009, 83(6):2417-2428. 10.1128/JVI.02392-08, 2648257, 19109384.
22. Johansson ME, Brown M, Hierholzer JC, Thorner A, Ushijima H, Wadell G. Genome analysis of adenovirus type 31 strains from immunocompromised and immunocompetent patients. J Infect Dis 1991, 163(2):293-299.
23. Leruez-Ville M, Chardin-Ouachee M, Neven B, Picard C, Le Guinche I, Fischer A, Rouzioux C, Blanche S. Description of an adenovirus A31 outbreak in a paediatric haematology unit. Bone Marrow Transplant 2006, 38(1):23-28. 10.1038/sj.bmt.1705389, 16699529.
24. Brudno M, Do CB, Cooper GM, Kim MF, Davydov E, Green ED, Sidow A, Batzoglou S. LAGAN and Multi-LAGAN: efficient tools for large-scale multiple alignment of genomic DNA. Genome Res 2003, 13(4):721-731. 10.1101/gr.926603, 430158, 12654723.
25. De Jong JC, Wermenbol AG, Verweij-Uijterwaal MW, Slaterus KW, Wertheim-Van Dillen P, Van Doornum GJ, Khoo SH, Hierholzer JC. Adenoviruses from human immunodeficiency virus-infected individuals, including two strains that represent new candidate serotypes Ad50 and Ad51 of species B1 and D, respectively. J Clin Microbiol 1999, 37(12):3940-3945. 85850, 10565911.
26. Purkayastha A, Ditty SE, Su J, McGraw J, Hadfield TL, Tibbetts C, Seto D. Genomic and bioinformatics analysis of HAdV-4, a human adenovirus causing acute respiratory disease: implications for gene therapy and vaccine vector development. J Virol 2005, 79(4):2559-2572. 10.1128/JVI.79.4.2559-2572.2005, 546560, 15681456.
27. Hatfield L, Hearing P. Redundant elements in the adenovirus type 5 inverted terminal repeat promote bidirectional transcription in vitro and are important for virus growth in vivo. Virology 1991, 184:265-276. 10.1016/0042-6822(91)90843-Z, 1871971.
28. Bruder JT, Hearing P. Cooperative binding of EF-1A to the E1A enhancer region mediates synergistic effects on E1A transcription during adenovirus infection. J Virol 1991, 65(9):5084-5087. 248974, 1651424.
29. Avvakumov N, Wheeler R, D'Halluin JC, Mymryk JS. Comparative sequence analysis of the largest E1A proteins of human and simian adenoviruses. J Virol 2002, 76(16):7968-7975. 10.1128/JVI.76.16.7968-7975.2002, 155151, 12134001.
30. Huvent I, Cousin C, Kiss A, Bernard C, D'Halluin JC. Susceptibility to natural killer cells and down regulation of MHC class I expression in adenovirus 12 transformed cells are regulated by different E1A domains. Virus research 1996, 45:123-134. 10.1016/S0168-1702(96)01367-6, 8896247.
31. Geisberg JV, Lee WS, Berk AJ, Ricciardi RP. The zinc finger region of the adenovirus E1A transactivating domain complexes with the TATA box binding protein. Proc Natl Acad Sci USA 1994, 91(7):2488-2492. 10.1073/pnas.91.7.2488, 43394, 8146144.
32. Berk AJ. Recent lessons in gene expression, cell cycle control, and cell biology from adenovirus. Oncogene 2005, 24(52):7673-7685. 10.1038/sj.onc.1209040, 16299528.
33. Querido E, Blanchette P, Yan Q, Kamura T, Morrison M, Boivin D, Kaelin WG, Conaway RC, Conaway JW, Branton PE. Degradation of p53 by adenovirus E4orf6 and E1B55K proteins occurs via a novel mechanism involving a Cullin-containing complex. Genes Dev 2001, 15(23):3104-3117. 10.1101/gad.926401, 312842, 11731475.
34. Blanchette P, Cheng CY, Yan Q, Ketner G, Ornelles DA, Dobner T, Conaway RC, Conaway JW, Branton PE. Both BC-box motifs of adenovirus protein E4orf6 are required to efficiently assemble an E3 ligase complex that degrades p53. Mol Cell Biol 2004, 24(21):9619-9629. 10.1128/MCB.24.21.9619-9629.2004, 522240, 15485928.
35. Lee KA, Green MR. A cellular transcription factor E4F1 interacts with an E1a-inducible enhancer and mediates constitutive enhancer function in vitro. Embo J 1987, 6(5):1345-1353. 553939, 2956091.
36. Horwitz MS. Function of adenovirus E3 proteins and their interactions with immunoregulatory cell proteins. The journal of gene medicine 2004, 6(Suppl 1):S172-183. 10.1002/jgm.495, 14978760.
37. Windheim M, Hilgendorf A, Burgert HG. Immune evasion by adenovirus E3 proteins: exploitation of intracellular trafficking pathways. Current topics in microbiology and immunology 2004, 273:29-85.
38. Sprengel J, Schmitz B, Heuss-Neitzel D, Zock C, Doerfler W. Nucleotide sequence of human adenovirus type 12 DNA: comparative functional analysis. J Virol 1994, 68(1):379-389. 236298, 8254750.
39. Burgert HG, Blusch JH. Immunomodulatory functions encoded by the E3 transcription unit of adenoviruses. Virus Genes 2000, 21(1-2):13-25. 10.1023/A:1008135928310, 11022786.
40. Krajcsi P, Tollefson AE, Anderson CW, Wold WS. The adenovirus E3 14.5-kilodalton protein, which is required for down-regulation of the epidermal growth factor receptor and prevention of tumor necrosis factor cytolysis, is an integral membrane protein oriented with its C terminus in the cytoplasm. J Virol 1992, 66(3):1665-1673. 240906, 1531370.
41. Davison AJ, Benko M, Harrach B. Genetic content and evolution of adenoviruses. J Gen Virol 2003, 84(Pt 11):2895-2908. 10.1099/vir.0.19497-0, 14573794.
42. Akalu A, Liebermann H, Bauer U, Granzow H, Seidel W. The subgenus-specific C-terminal region of protein IX is located on the surface of the adenovirus capsid. Journal of virology 1999, 73:6182-6187. 112689, 10364380.
43. Lupas A, Van Dyke M, Stock J. Predicting coiled coils from protein sequences. Science (New York, NY) 1991, 252(5009):1162-1164.
44. Lutz P, Kedinger C. Properties of the adenovirus IVa2 gene product, an effector of late-phase-dependent activation of the major late promoter. Journal of virology 1996, 70:1396-1405. 189959, 8627656.
45. Wickham TJ, Mathias P, Cheresh DA, Nemerow GR. Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment. Cell 1993, 73(2):309-319. 10.1016/0092-8674(93)90231-E, 8477447.
46. Mathias P, Wickham T, Moore M, Nemerow G. Multiple adenovirus serotypes use alpha v integrins for infection. J Virol 1994, 68(10):6811-6814. 237109, 8084019.
47. Karayan L, Hong SS, Gay B, Tournier J, d'Angeac AD, Boulanger P. Structural and functional determinants in adenovirus type 2 penton base recombinant protein. J Virol 1997, 71(11):8678-8689. 192332, 9343226.
48. Chatterjee NK, Samsonoff WA, Balasubramaniam N, Rush-Wilson K, Spargo W, Church TM. Isolation and characterization of adenovirus 5 from the brain of an infant with fatal cerebral edema. Clin Infect Dis 2000, 31(3):830-833. 10.1086/314041, 11017844.
49. Honkavuori KS, Pollard BD, Rodriguez MS, Hay RT, Kemp GD. Dual role of the adenovirus pVI C terminus as a nuclear localization signal and activator of the viral protease. J Gen Virol 2004, 85(Pt 11):3367-3376. 10.1099/vir.0.80203-0, 15483253.
50. Mahr JA, Gooding LR. Immune evasion by adenoviruses. Immunol Rev 1999, 168:121-130. 10.1111/j.1600-065X.1999.tb01287.x, 10399069.
51. Burgert HG, Ruzsics Z, Obermeier S, Hilgendorf A, Windheim M, Elsing A. Subversion of host defense mechanisms by adenoviruses. Curr Top Microbiol Immunol 2002, 269:273-318.
52. Barclay AN BM, Law SKA, McNight AJ, Tomlinson MG, Merwe PA. The Leukocyte Antigen Factsbook. 1997, San Diego, CA, USA: Academic Press.
53. McSharry BP, Burgert HG, Owen DP, Stanton RJ, Prod'homme V, Sester M, Koebernick K, Groh V, Spies T, Cox S. Adenovirus E3/19K promotes evasion of NK cell recognition by intracellular sequestration of the NKG2D ligands major histocompatibility complex class I chain-related proteins A and B. J Virol 2008, 82(9):4585-4594. 10.1128/JVI.02251-07, 2293069, 18287244.
54. Andersson M, Paabo S, Nilsson T, Peterson PA. Impaired intracellular transport of class I MHC antigens as a possible means for adenoviruses to evade immune surveillance. Cell 1985, 43(1):215-222. 10.1016/0092-8674(85)90026-1, 2934137.
55. Burgert HG, Kvist S. An adenovirus type 2 glycoprotein blocks cell surface expression of human histocompatibility class I antigens. Cell 1985, 41(3):987-997. 10.1016/S0092-8674(85)80079-9, 3924414.
56. Hall KT, Blair GE. The mechanism of down-regulation of major histocompatibility complex (MHC) class I antigens in highly oncogenic adenovirus 12-transformed cells. Biochem Soc Trans 1997, 25(2):353S.
57. Subramanian T, Vijayalingam S, Chinnadurai G. Genetic identification of adenovirus type 5 genes that influence viral spread. J Virol 2006, 80(4):2000-2012. 10.1128/JVI.80.4.2000-2012.2006, 1367173, 16439556.
58. Forstmeyer D, Henke-Gendo C, Bröcker V, Wildner O, Heim A. Quantitative temporal and spatial distribution of adenovirus type 2 correlates with disease manifestations and organ failure during disseminated infection. Journal of medical virology 2008, 80:294-297. 10.1002/jmv.21071, 18098135.
59. Dmitriev IP, Kashentseva EA, Curiel DT. Engineering of adenovirus vectors containing heterologous peptide sequences in the C terminus of capsid protein IX. J Virol 2002, 76(14):6893-6899. 10.1128/JVI.76.14.6893-6899.2002, 136342, 12072490.
60. Zakhartchouk A, Connors W, van Kessel A, Tikoo SK. Bovine adenovirus type 3 containing heterologous protein in the C-terminus of minor capsid protein IX. Virology 2004, 320(2):291-300. 10.1016/j.virol.2003.12.007, 15016551.
61. Ebner K, Pinsker W, Lion T. Comparative sequence analysis of the hexon gene in the entire spectrum of human adenovirus serotypes: phylogenetic, taxonomic, and clinical implications. J Virol 2005, 79(20):12635-12642. 10.1128/JVI.79.20.12635-12642.2005, 1235814, 16188965.
62. Finn RD, Tate J, Mistry J, Coggill PC, Sammut SJ, Hotz HR, Ceric G, Forslund K, Eddy SR, Sonnhammer EL. The Pfam protein families database. Nucleic Acids Res 2008, (36 Database):D281-288. 2238907, 18039703.
63. Hulo N, Bairoch A, Bulliard V, Cerutti L, Cuche BA, de Castro E, Lachaize C, Langendijk-Genevaux PS, Sigrist CJ. The 20 years of PROSITE. Nucleic Acids Res 2008, (36 Database):D245-249. 2238851, 18003654.
64. Krogh A, Larsson B, von Heijne G, Sonnhammer EL. Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes. J Mol Biol 2001, 305(3):567-580. 10.1006/jmbi.2000.4315, 11152613.
65. Hiller K, Grote A, Maneck M, Munch R, Jahn D. JVirGel 2.0: computational prediction of proteomes separated via two-dimensional gel electrophoresis under consideration of membrane and secreted proteins. Bioinformatics 2006, 22(19):2441-2443. 10.1093/bioinformatics/btl409, 16870933.
66. Hiller K, Schobert M, Hundertmark C, Jahn D, Munch R. JVirGel: Calculation of virtual two-dimensional protein gels. Nucleic Acids Res 2003, 31(13):3862-3865. 10.1093/nar/gkg536, 168943, 12824438.